Biotest: Q3 2013 Results (Biotest) - Nov 13, 2013 - "ACR scores achieved at week 13 up to: ACR 20: 56%, ACR 50: 37%, ACR 70: 7%"; "Good tolerability observed in previous trials confirmed"; "Pharmacodynamic data indicate that higher doses of Tregalizumab could provide even higher efficacy"
P2 data • Rheumatoid Arthritis
|